Drug Target Review – Issue #2 2018
Posted: 31 May 2018 | Drug Target Review | No comments yet
In this issue: the positive impact of genomics on drug discovery, development and deployment, the confluence of biology and technology, and Artificial Intelligence: harnessing the potential to drive progress in drug discovery promises much for phenotypic drug discovery
Included in this edition:
- GENOMICS: Genomics in drug development and safety testing; from target identification to genomic toxicology
Adam David Thomas, University of the West of England - SCREENING: Regenerative medicine: enhance cell bioprocessing through cell-based combinatorial culture
Shahzad Ali, Plasticell Ltd - ARTIFICIAL INTELLIGENCE: Adapting drug discovery to Artificial Intelligence
George Okafo, Vishal Sahni, John Baldoni, Michael Palovich, Ami S Lakdawala and Tobias Sikosek, GSK’s In-silico drug discover unit - STEM CELLS: The role of biomaterials in stem cell-based regenerative medicine
Laura Goldie, Biogelx Ltd - IMAGING: Applications of molecular imaging in drug development
Ben Burke and Stephen Archibald, PET Research Centre, University of Hull
Issue #2 2018 of Drug Target Review is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related topics
Artificial Intelligence, Genomics, Imaging, Screening, Stem Cells
